Feinwerktechnik

Eintrag vom: 15.09.2013.

The attention of all pharmacy staff is drawn to the restrictions on the use of unlicensed medicines imposed under the Human Medicines Regulations 2012 and described fully in MHRA Guidance Note 14 (revised 2014) ?The supply of unlicensed relevant medicinal products for individual patients?.

 

This Guidance Note provides advice on the manufacture importation distribution and supply of unlicensed medicinal products for human use (commonly described as ?specials?) which have been specially manufactured or imported to the order of a doctor dentist nurse independent prescriber pharmacist independent prescriber or supplementary ...

 

The framework described in Guidance Note 14 is seen as an appropriate means of giving the legal method for the sponsor to actually obtain the NIMP otherwise there would be no legal basis for...

 

APPENDIX 2 - Guidance on the hierarchy for the use of unlicensed medicines This hierarchy is provided for guidance only and each case should be considered on its individual merit.

 

MHRA guidance on the lawful supply and use of unlicensed medicines is set out in the MHRA publication ?The supply of unlicensed medicinal products (?specials?)? MHRA Guidance Note 14. You should usually propose prescribe or provide licensed medicines in accordance with the terms of their licence.